Sequential therapy with bevacizumab and EGFR inhibitors for metastatic colorectal carcinoma: a national registry-based analysis

PURPOSE: Although inhibitors of vascular endothelial growth factor and inhibitors of epidermal growth factor receptor (EGFRi) are commonly used for the treatment of metastatic colorectal cancer (mCRC), the optimal sequencing of these agents is currently unclear. METHODS: A national registry of targe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer Manag Res
Autores principales: Buchler, Tomas, Chloupkova, Renata, Poprach, Alexandr, Fiala, Ondrej, Kiss, Igor, Kopeckova, Katerina, Dusek, Ladislav, Veskrnova, Veronika, Slavicek, Lubomir, Kohoutek, Milan, Finek, Jindrich, Svoboda, Marek, Petruzelka, Lubos, Melichar, Bohuslav
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6314050/
https://ncbi.nlm.nih.gov/pubmed/30643461
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S183093
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares